Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Death × Diet × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Motor Activity 12 Breast Neoplasms 9 Polycystic Ovary Syndrome 8 Obesity 8 Colorectal Neoplasms 6 Weight Loss 5 Prostatic Neoplasms 5 Neoplasms 4 Colonic Neoplasms 4 Multiple Endocrine Neoplasia Type 1 3 Pancreatic Neoplasms 2 Overweight 2 Malnutrition 2 Lymphoma, Follicular 2 Lymphoma 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Waldenstrom Macroglobulinemia 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Smoking 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Compliance 1

Interventions

Surveys and Questionnaires 3 Standard of Care 3 erythromycin propionate-N-acetylcysteinate 1 Therapeutics 1 Practice Guidelines as Topic 1 Palliative Care 1 Midazolam 1 Mass Screening 1 Interviews as Topic 1 Genes, p53 1 Focus Groups 1 Exercise 1 Diet 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03424668 2019-04-16

EPIC-Norfolk

University of Cambridge

Active not recruiting

25,639 enrolled

Cardiovascular Diseases, Death, Motor Activity, Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon ⚡